March 24 (Reuters) - InMed Pharmaceuticals Inc IN.TO :
* INMED SUBMITS CLINICAL TRIAL APPLICATION TO EVALUATE INM-755 IN SECOND PHASE 1 TRIAL
March 24 (Reuters) - InMed Pharmaceuticals Inc IN.TO :
* INMED SUBMITS CLINICAL TRIAL APPLICATION TO EVALUATE INM-755 IN SECOND PHASE 1 TRIAL